SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.70-0.1%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey Boggis who wrote (1550)4/23/1998 11:04:00 PM
From: Barron Von Hymen  Read Replies (1) of 9523
 
Use the Schwartz! Not. Thursday April 23, 8:17 pm Eastern Time

RESEARCH ALERT-Hypo cuts Schwarz Pharma

MUNICH, Germany, April 23 (Reuters) - Analysts at Bayerische Hypotheken- und Wechsel-Bank AG (BHWG.F) on
Thusday cut drugs group Schwarz Pharma AG (SRZG.F) to ''market performer'' from ''outperformer.''

The bank said there was increased pressure on Schwarz Pharma's EDEX/Viridal product because of the successful introduction
by Pfizer Inc (PFE - news) of its impotence drug Viagra.

In addition, Hypo-Bank said that Schwarz Pharma's change of strategy on its range of operations was worrying.

Analyst Isabella Zinck said in a comment that Schwarz Pharma was planning to realise ''all good projects'' regardless of
segment, having earlier said it was going to focus on core areas.

This would bring Schwarz Pharma into regions dominated by larger rivals, she said.

''It will be a significant battle for Schwarz Pharma to compete here, the danger of inefficiencies is high.''
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext